Unimicron Technology (3037) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
26 Aug, 2026Executive summary
Q2 2026 net sales reached NT$42,890 million, up 15% quarter-over-quarter and 32% year-over-year.
Net income for Q2 2026 was NT$13,342 million, representing a 148% increase year-over-year.
Consolidated financial statements for the six months ended June 30, 2026, were reviewed and found to present fairly in all material respects under applicable regulations and standards.
The group operates primarily in the manufacturing and sales of printed circuit boards and electronic products, with 31,584 employees as of June 30, 2026.
Gross margin improved to 24.8% in Q2 2026 from 18.0% in Q1 2026 and 13.1% in Q2 2025.
Financial highlights
Operating income for Q2 2026 was NT$6,651 million, up 141% quarter-over-quarter and 341% year-over-year.
EBITDA for Q2 2026 was NT$20,939 million, 49% of sales.
Basic EPS for Q2 2026 was NT$8.45, compared to NT$3.28 in Q1 2026 and NT$0.02 in Q2 2025.
Sales revenue for the six months ended June 30, 2026, was $80,336,273 thousand, up from $62,555,577 thousand year-over-year.
Net profit for the period was $18,723,125 thousand, a significant increase from $1,183,686 thousand year-over-year.
Outlook and guidance
Forward-looking statements highlight risks and uncertainties that may impact future performance.
The group is pursuing strategic asset sales and capital increases, including a GDR issuance and planned listing of a subsidiary in Hong Kong.
Ongoing business integration and resource optimization in Mainland China, with asset disposals and equity transfers in progress.
Latest events from Unimicron Technology
- Q1 2026 net sales and income surged, led by substrate, automotive, and strategic investments.3037
Q1 2026 - Sales and net income rose sharply, driven by substrate and automotive growth, with higher cash reserves.3037
Q4 2025 - Net sales up 12% to NT$96.55B, net income down 38%, with new bonds and HK listing planned.3037
Q3 2025 - Revenue up 15% but profit and margins fell sharply amid major merger and FX risks.3037
Q2 2025 - Sales up 13.8% in Q3 2024, but net income and margins declined amid expansion efforts.3037
Q3 2024 - Revenue rose but profit and margins fell due to higher costs and margin pressure.3037
Q2 2024 - Q1 2025 revenue rose 14% year-over-year, but net income and margins declined.3037
Q1 2025 - Sales up 11%, net income down 55–58%, dividend proposed, inventory risk persists.3037
Q4 2024